Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02404402 · ClinicalTrials.gov registry record · NA
LED Treatment to Improve Cognition and Promote Recovery in TBI
A NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT02404402: Active NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury, sponsored by VA Office of Research and Development.
NCT02404402 is a NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 8 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02404402, a NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the efficacy of a novel neuromodulation treatment, light emitting diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with traumatic brain injury (TBI).
Primary Outcome
Stroop Test ("Color-Word" test; Delis, Kaplan \& Kramer, 2001)
Conditions Studied
Interventions
- OTHER LED
- OTHER sham LED
Study Locations (1)
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-05-01 |
| Est. Completion | 2027-10-31 |
| Phase | NA |
What the registry record for NCT02404402 still lists
NCT02404402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which LED is the first listed.
NCT02404402 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02404402 about?
NCT02404402 is a clinical study titled "LED Treatment to Improve Cognition and Promote Recovery in TBI". This study investigates the efficacy of a novel neuromodulation treatment, light emitting diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with traumatic brain injury (TBI).
What is the current status of trial NCT02404402?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2015-05-01. Estimated completion is 2027-10-31.
What conditions does trial NCT02404402 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Traumatic Brain Injury.
What interventions are being tested in trial NCT02404402?
The interventions under investigation include: LED (OTHER), sham LED (OTHER).
Who is sponsoring clinical trial NCT02404402?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02404402 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02404402's enrollment target sits among peer trials
8 256th of 262 higher than 5 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI